Pular para conteúdo

Oncologia (pediatria) 

Quimioterapia individualizada ou modificada (com ajuste de dose ou adiada)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (abre nova janela)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Fonte‎: N Engl J Med 1998;338(8):499-505.

Indexado‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (abre nova janela)

Childhood cancer and the Jehovah's Witness faith. (abre nova janela)

Frankel LS, Damme CJ, Eys JV.

Fonte‎: Pediatrics 1977;60(6):916-21.

Indexado‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (abre nova janela)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (abre nova janela)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Fonte‎: J Clin Oncol 2004;22(24):4888-92.

Indexado‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (abre nova janela)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (abre nova janela)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Fonte‎: JAMA Oncol 2022;8(1):79-87. 

Indexado‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (abre nova janela)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (abre nova janela)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Fonte‎: Haematologica 2000;85(11):1221-2.

Indexado‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (abre nova janela)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (abre nova janela)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Fonte‎: Bone Marrow Transplant 2016;51(7):1002-3.

Indexado‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (abre nova janela)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (abre nova janela)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Fonte‎: Bone Marrow Transplant 2003;32(4):433-6.

Indexado‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (abre nova janela)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (abre nova janela)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Fonte‎: Bone Marrow Transplant 2005;36(8):715-20.

Indexado‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (abre nova janela)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (abre nova janela)

Zwaan CM, Kaspers GJ

Fonte‎: Br J Haematol 2004;127(3):264-79.

Indexado‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (abre nova janela)